Eagle Global Advisors’s Syneron Medical Ltd ELOS Stock Holding History

Eagle Global Advisors’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-45,100	Closed	-$494K	–	434
2017 Q2	$494K	Sell	45,100 -14,000	-24%	-$154K	0.01%	218
2017 Q1	$624K	Buy	59,100 +33,000	+126%	+$319K	0.02%	191
2016 Q4	$219K	Buy	+26,100	New	+$205K	0.01%	316
2014 Q2	–	Sell	-20,000	Closed	-$249K	–	348
2014 Q1	$249K	Buy	20,000 +3,000	+18%	+$35.5K	0.01%	251
2013 Q4	$209K	Hold	17,000	–	–	0.01%	228
2013 Q3	$147K	Hold	17,000	–	–	0.01%	231
2013 Q2	$148K	Buy	+17,000	New	+$152K	0.01%	225

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Eagle Global Advisors's ELOS Position: Q3 2017 in Review

Eagle Global Advisors sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 45,100 shares — an estimated $494K sold.

Eagle Global Advisors first reported a position in ELOS in Q2 2013 and held it in 7 quarters. The position peaked at $624K in Q1 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

Eagle Global Advisors reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
Eagle Global Advisors sold 45,100 Syneron Medical Ltd shares in Q3 2017, an estimated $494K.
Eagle Global Advisors first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 7 quarters.
Eagle Global Advisors's Syneron Medical Ltd position peaked at $624K in Q1 2017.
4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Eagle Global Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.